TrialBritish journal of cancer2008

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.

R Fruscio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.